Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
about
Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Tadalafil has biologic activit ...... ith metastatic Melanoma (TaMe)
@en
type
label
Tadalafil has biologic activit ...... ith metastatic Melanoma (TaMe)
@en
prefLabel
Tadalafil has biologic activit ...... ith metastatic Melanoma (TaMe)
@en
P2093
P2860
P50
P1433
P1476
Tadalafil has biologic activit ...... ith metastatic Melanoma (TaMe)
@en
P2093
Alexander Enk
Alexandra Sevko
Dirk Jäger
Huanhuan Jiang
Ivan Shevchenko
Jessica C Hassel
Julia Winkler
Niels Halama
Viktor Umansky
Walter E Haefeli
P2860
P304
P356
10.1080/2162402X.2017.1326440
P577
2017-05-16T00:00:00Z